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Abstract: This report describes a patient who had exaggerated responses to different 
inflammatory stimuli represented by laser and incisional surgery, respectively. These separate 
episodes should have a common link represented by a genetic predisposition to abnormal release 
of proinflammatory mediators within the eye. This 51-year old Hispanic woman showed a nar-
row iridocorneal angle with plateau iris configuration. Nd-YAG laser peripheral iridotomy was 
successfully performed to both eyes. No substantial changes in the iridotrabecular angle occurred 
despite patent iridotomies, thus confirming the diagnosis of plateau iris configuration. Argon 
laser iridoplasty was then performed to the right eye, while the left eye was scheduled for a later 
session. A severe inflammatory reaction within the anterior chamber developed after tapering 
of a one-week course of steroid therapy. Phacoemulsification of the lens was performed some 
months later when no signs of inflammation were detectable; no intraoperative complications 
occurred during surgery and an intraocular lens was placed. Cystoid macular edema developed 
four weeks after surgery despite no apparent risk factors, and resolved completely after anti-
inflammatory medical therapy. Based on this case report, the unusual occurrence of severe iritis 
after laser treatment should be regarded as a risk factor for any other incisional or nonincisional 
procedures because it might indicate that the patient’s ocular tissues are prone to release of 
abnormally elevated proinflammatory mediators. Although further studies are needed to con-
firm this predisposition, prophylactic adjunctive topical nonsteroidal anti-inflammatory drug 
administration after cataract surgery should be considered in such cases in order to prevent 
potentially sight-threatening conditions.
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Introduction
This report describes a patient who had exaggerated responses to inflammatory stimuli. 
Argon laser peripheral iridoplasty (ALPI) is considered a safe procedure for the manage-
ment of plateau iris configuration.1 A well recognized cause of primary angle-closure 
glaucoma, plateau iris configuration is defined anatomically as a narrow or closed 
angle, as determined by gonioscopy, in the presence of a flat iris plane and a normal-
depth anterior chamber.2 This condition is the result of variations in iris and ciliary 
body anatomy that bring the peripheral iris into contact with the trabecular meshwork.3 
Almost all eyes undergoing ALPI develop a mild iritis,4 which is usually well controlled 
by topical steroids administered during the 4–7 days following the procedure.
Cystoid macular edema (CME) is a well recognized cause of decreased visual acuity 
after cataract surgery and its etiology is not fully understood.5 Different factors, such as 
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(eg, diabetes), age, and drugs (eg, latanoprost) have been 
suggested to contribute to its pathogenesis.6–8 Patients with 
uveitis are known to be at higher risk of CME after cataract 
surgery, and inflammation seems to play a pivotal role in its 
development.9,10
Case report
A 51-year old Hispanic woman was referred to our practice 
with a diagnosis of “occludable angle”. She denied any 
systemic disorder, except for mild systemic hypertension, 
and the history was negative for eye diseases or treatments. 
The visual acuity was 1.0 in both eyes with a refraction 
of +0.50 sph OU. Anterior segment examination showed thin-
looking peripheral anterior chambers with regular pupils 
reacting to light and dark pigmented irises. Gonioscopy 
revealed bilateral narrow angles throughout the entire 
circumference, with a plateau configuration appreciable 
in 270° of the circumference and no peripheral   anterior 
synechiae (PAS).   Nd-YAG laser peripheral iridotomy 
was successfully performed to both eyes. At a one-week 
follow-up visit, gonioscopy did not reveal any important 
changes in the iridotrabecular angle configuration, thus 
confirming the diagnosis of plateau iris configuration. 
Using the central nonmirrored part of a Goldman lens, 
ALPI was performed to the right eye by placing 32 argon 
laser burns (500 µm spot size, 500 msec duration, 350 mW 
power) circumferentially at the periphery of the iris. One 
week after discontinuation of a six-day course of topical 
dexamethasone 0.1% four times daily, slit lamp examina-
tion revealed a severe inflammatory reaction within the 
anterior chamber, a myotic pupil nonreactive to light, with 
two posterior synechiae and an intraocular pressure (IOP) 
of 30 mmHg. She was treated with topical dexamethasone 
0.2% five times daily and acetazolamide 250 mg twice 
daily. One week after she was asymptomatic, a minimum 
flare, posterior synechiae and mild lens opacity were then 
identifiable; gonioscopy showed circumferential iris appo-
sition with diffuse PAS , as shown in Figure 1. One month 
afterwards, no inflammatory cells were detectable within the 
anterior chamber and the vitreous, IOP was 20 mmHg under 
treatment (timolol 0.5% + dorzolamide 2% twice daily and 
acetazolamide 250 mg twice daily), and the best corrected 
visual acuity (BCVA) was 0.8. The IOP was increasing after 
discontinuation of the medical treatment, so that four months 
after the acute episode when the patient was asymptomatic 
with no redness, flare, keratic precipitates, or other signs of 
active inflammation detectable, phacoemulsification of the 
lens was performed.11
No complications occurred during surgery, and a 
posterior chamber intraocular lens was well placed. The 
patient was prescribed a combination of dexamethasone 
0.1% + netilmicin 0.5% five times daily. One week after 
surgery, the visual acuity was excellent (BCVA 1.0). Steroid 
therapy was then gradually decreased during the following 
two weeks, at which time a CME developed and the BCVA 
decreased to 0.4. After four weeks of treatment with topi-
cal diclofenac four times daily and acetazolamide 125 mg 
twice daily, visual acuity completely recovered (BCVA 1.0), 
no cystoid macular edema was appreciable, and it has not 
recurred up until now. Figure 2 shows three optical coher-
ence tomographic images demonstrating gradually improv-
ing CME.
Discussion
Two major events have been described in this case report, 
ie, the occurrence of an unusual inflammatory reaction after 
ALPI performed for plateau iris syndrome and the onset 
of cystoid macular edema following phacoemulsification 
performed on a second occasion in the same eye. Because 
the occurrence of clinical cystoid macular edema after 
uncomplicated cataract surgery has a relatively low overall 
prevalence of less than 3%,10 we postulate that a causative 
link between acute post-laser iritis and onset of CME 
existed in our patient. This could be represented by a 
genetically determined predisposition to overexpression of 
inflammatory pathways after mechanical or thermal trauma 
in both the anterior and posterior segments of the eye.12
The exact etiological mechanisms leading to CME are 
not completely understood.13 A widely supported theory 
is that inflammatory mediators released from the anterior 
segment traverse the vitreous, reach the posterior seg-
ment, and disturb the blood–retinal barrier in the macular 
area, leading to accumulation of intraretinal fluid.14 It is 
known that the iris is a metabolically active tissue able 
to release inflammatory mediators when injured,15 and 
proinflammatory cytokines have been demonstrated to be 
released, possibly in different amounts, after both Nd:YAG 
Figure 1 Anterior segment optical coherence tomography imaging. The picture 
shows a persisting irido-corneal contact despite central deepening of the anterior 
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and argon laser iridotomy.16,17 In particular, interleukin-6, 
prostaglandin E2, and tumor necrosis factor-alpha may 
accumulate in the aqueous humor after laser applica-
tion to the iris,16,17 leading to the onset of a variable and 
  possibly subclinical inflammation. Cataract surgery could 
result in intraocular barrier breakdown and diffusion of 
inflammatory cytokines into the vitreous fluid, thus leading 
to the development of CME.
Cases of marked inflammation after tapering anti-
inflammatory steroid therapy following Nd:YAG laser 
iridotomy have been described, and heavy pigmentation 
of the iris linked to race has been recognized as a possible 
predisposing factor.18 Similarly, our patient had a dark iris, 
and this anatomical feature could have played a role in the 
inflammatory process. To our knowledge, this is the first 
paper reporting the occurrence of post-ALPI inflammation 
that was severe and beyond the degree of mild iritis. 
Moreover, this event has never been proposed as a risk 
factor for CME. Because no other predisposing conditions 
were identifiable (ie, chronic uveitis, rheumatologic or 
autoimmune disorders, diabetes, use of prostaglandin 
analogs, intraoperative complications),7,15 our patient 
did not receive prophylactic treatment with nonsteroidal 
anti-inflammatory drugs, and a routine course of topical 
steroids, but not nonsteroidals, was prescribed after surgery. 
For this reason, we do not know if use of nonsteroidal anti-
inflammatory drugs could have prevented the development 
of CME.
Conclusion
Based on this case report, a history of severe iritis after 
laser treatment could represent a predisposing condition 
for development of CME after cataract surgery. Although 
further studies are needed to confirm this association, the 
use of pharmacological agents able to protect against this 
potentially sight-threatening condition should be considered 
in such cases.1
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